Testing effectiveness (Phase 2)Ended earlyNCT01235793
What this trial is testing
The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma
Who this might be right for
B-Cell Lymphoma Originating in the CNS
Cedars-Sinai Medical Center 11